Abstract is: The Framingham Heart Study is a long-term, ongoing cardiovascular cohort study of residents of the city of Framingham, Massachusetts. The study began in 1948 with 5,209 adult subjects from Framingham, and is now on its third generation of participants. Prior to the study almost nothing was known about the epidemiology of hypertensive or arteriosclerotic cardiovascular disease. Much of the now-common knowledge concerning heart disease, such as the effects of diet, exercise, and common medications such as aspirin, is based on this longitudinal study. It is a project of the National Heart, Lung, and Blood Institute, in collaboration with (since 1971) Boston University. Various health professionals from the hospitals and universities of Greater Boston staff the project.
clinical trial | Q30612 |
research group | Q1241025 |
cohort study | Q1778788 |
P3098 | ClinicalTrials.gov ID | NCT00005121 |
P646 | Freebase ID | /m/05455x |
P2427 | GRID ID | grid.510954.c |
P213 | ISNI | 0000000404443861 |
P6366 | Microsoft Academic ID | 111815664 |
P10283 | OpenAlex ID | C111815664 |
P3500 | Ringgold ID | 232885 |
P6782 | ROR ID | 031grv205 |
P17 | country | United States of America | Q30 |
P582 | end time | 2008-09-01 | |
P4135 | maximum age | 100 | |
P1050 | medical condition | stroke | Q12202 |
heart failure | Q181754 | ||
coronary artery disease | Q844935 | ||
atherosclerosis | Q12252367 | ||
P580 | start time | 1948-07-01 | |
P8363 | study type | observational study | Q818574 |
Q31049222 | A genome-wide linkage scan for body mass index on Framingham Heart Study families |
Q31049251 | A genome-wide scan to identify loci for smoking rate in the Framingham Heart Study population |
Q30907486 | A model-integrated multipoint Bayesian analysis of hypertension in the Framingham Heart Study data finds little evidence of linkage |
Q33198458 | Age-stratified heritability estimation in the Framingham Heart Study families |
Q40668398 | Antecedent blood pressure and risk of cardiovascular disease: the Framingham Heart Study . |
Q33198474 | Bivariate linkage analysis of cholesterol and triglyceride levels in the Framingham Heart Study |
Q31049150 | Bivariate variance-component analysis, with application to systolic blood pressure and total cholesterol levels in the Framingham Heart Study |
Q57244883 | Bone mass and the risk of prostate cancer: The Framingham study |
Q31049191 | Comparison between two analytic strategies to detect linkage to obesity with genetically determined age of onset: the Framingham Heart Study |
Q31049201 | Comparison of linkage analysis methods for genome-wide scanning of extended pedigrees, with application to the TG/HDL-C ratio in the Framingham Heart Study |
Q30907324 | Comparison of the linkage results of two phenotypic constructs from longitudinal data in the Framingham Heart Study: analyses on data measured at three time points and on the average of three measurements |
Q30907371 | Comparison of year-of-exam- and age-matched estimates of heritability in the Framingham Heart Study data |
Q33198456 | Consistency of linkage results across exams and methods in the Framingham Heart Study. |
Q33198468 | Evidence for bivariate linkage of obesity and HDL-C levels in the Framingham Heart Study |
Q40700314 | Genetic and environmental contributions to platelet aggregation: the Framingham heart study. |
Q31049197 | Genome scan for body mass index and height in the Framingham Heart Study |
Q31049155 | Genome scan linkage results for longitudinal systolic blood pressure phenotypes in subjects from the Framingham Heart Study |
Q30414223 | Genome-wide meta-analysis of homocysteine and methionine metabolism identifies five one carbon metabolism loci and a novel association of ALDH1L1 with ischemic stroke |
Q47388470 | Genomewide linkage analysis of weight change in the Framingham Heart Study |
Q31049244 | Genomic regions linked to alcohol consumption in the Framingham Heart Study |
Q31049228 | HDL cholesterol in females in the Framingham Heart Study is linked to a region of chromosome 2q. |
Q31831918 | Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance |
Q44433022 | Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study |
Q31048950 | Interaction of gender and body mass index (BMI) reveals evidence of linkage for hypertension in the Framingham Heart Study |
Q57073232 | Lifetime Risk for Developing Congestive Heart Failure |
Q35786651 | Linkage analysis of adult height with parent-of-origin effects in the Framingham Heart Study |
Q30907333 | Longitudinal variance-components analysis of the Framingham Heart Study data |
Q45057524 | Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study |
Q30907310 | Multilevel modeling for the analysis of longitudinal blood pressure data in the Framingham Heart Study pedigrees |
Q33198480 | Multiple genome-wide analyses of smoking behavior in the Framingham Heart Study |
Q31048942 | Multiple imputation methods for longitudinal blood pressure measurements from the Framingham Heart Study |
Q31049010 | Multivariate variance-components analysis of longitudinal blood pressure measurements from the Framingham Heart Study |
Q44342232 | Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study |
Q33198467 | Pedigree and genotype errors in the Framingham Heart Study |
Q40601658 | Plasma brain natriuretic peptide levels and blood pressure tracking in the Framingham Heart Study |
Q30907353 | Power of linkage analysis using traits generated from simulated longitudinal data of the Framingham Heart Study |
Q44811019 | Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study |
Q46507421 | Secondary hyperparathyroidism and bone turnover in elderly blacks and whites |
Q44269772 | Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study |
Q47637087 | The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study |
Q44779306 | The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study |
Q31048972 | Transmission ratio distortion in families from the Framingham Heart Study |
Q33198432 | Variance components linkage analysis for adjusted systolic blood pressure in the Framingham Heart Study |
Q28943291 | Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project |
Q92091243 | Landmark studies in coronary heart disease epidemiology. The Framingham Heart Study after 70 years and the Seven Countries Study after 60 years |
Q64103449 | Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts |
Q64120937 | Modeling a bivariate residential-workplace neighborhood effect when estimating the effect of proximity to fast-food establishments on body mass index |
Q37839316 | Matthew P. Pase | educated at | P69 |
Q88264418 | Daniel Levy | affiliation | P1416 |
Q5478027 | Framingham Risk Score | subclass of | P279 |
Category:Framingham Heart Study | wikimedia | |
Arabic (ar / Q13955) | دراسة فرامنغهام للقلب | wikipedia |
Framingham-Herz-Studie | wikipedia | |
Framingham Heart Study | wikipedia | |
Estudio de Framingham | wikipedia | |
Persian (fa / Q9168) | مطالعهی قلب فرامینگهام | wikipedia |
Étude de Framingham | wikipedia | |
סולם פרמינגהם | wikipedia | |
Framinghamska studija | wikipedia | |
Framingham Heart Study | wikipedia | |
Estudo de Framingham | wikipedia |
Search more.